Look for:

Products

MODERNA INC.


ISIN:
US60770K1079
WKN:
60770K107

2024/03/28 21:30:00
Price
106.56 USD
Difference -3.64% (-4.03)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,999 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)106.56 USD (500)
Ask (Ask size)107.11 USD (1,000)
Open111.10 USD
High112.00 USD
Low105.95 USD
Close (prev. day)110.59 USD
VWAP107.549566 USD
Volume (pcs)3,930,282
Trading volume422,650,478.03
Number of trades52,020
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: MODERNA INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 21:30:00
Price
106.56 USD
Difference -3.64% (-4.03)

General attributes

ISINUS60770K1079
SymbolMRNA
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,999 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)106.56 USD (500)
Ask (Ask size)107.11 USD (1,000)
Open111.10 USD
High112.00 USD
Low105.95 USD
Close (prev. day)110.59 USD
VWAP107.549566 USD
Volume (pcs)3,930,282
Trading volume422,650,478.03
Number of trades52,020
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+11.21%-25.45%-17.02%
Perf (abs.)+11.15-37.76-22.69
Beta1.371.081.29
Volatility56.1650.2266.64
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)107.58 USD (3,317,653)
Ø price 30 days | Ø volume 30 days (pcs.)99.66 USD (4,278,664)
Ø price 100 days | Ø volume 100 days (pcs.)92.79 USD (4,715,687)
Ø price 250 days | Ø volume 250 days (pcs.)107.76 USD (4,085,823)
YTD High | date115.97 USD (2024/01/08)
YTD Low | date84.06 USD (2024/02/13)
52 Weeks High | date163.24 USD (2023/04/14)
52 Weeks Low | date62.55 USD (2023/11/02)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/03/2817:3598.80 EUR0.52152
Vienna Stock Exchange2024/03/2817:3298.91 EUR0.024
Tradegate2024/03/2821:0398.48 EUR1.05183
Stuttgart2024/03/2812:32102.40 EUR0.065
Nasdaq2024/03/2821:30106.56 USD422.6552,020
Munich2024/03/2810:55102.70 EUR0.013
London Stock Exchange European Trade Reporting2024/03/2817:30107.24 USD0.0019
Hanover2024/03/2808:10101.58 EUR0.001
Hamburg2024/03/2808:10101.58 EUR0.001
Frankfurt2024/03/2816:5199.02 EUR0.0810
Euronext Milan MTF Trading After Hours2024/03/2220:1994.33 EUR0.001
Euronext Milan MTF Global Equity Market2024/03/2817:4499.02 EUR0.3055
Duesseldorf2024/03/2820:3798.49 EUR0.007
Berlin2024/03/2820:2198.99 EUR0.0016
BX Swiss2024/03/2818:0098.981 CHF0.012

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=144067&ID_TYPE_IMAGE_LOGO=2

Contact Details

MODERNA INC.
- -
200 Technology Square - 02139 Cambridge
Telefon: +1-617-714-6500
Fax: +617-583-1998
E-mail: info@modernatx.com

PDF Downloads

Company report: MODERNA INC.PDF Download

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Members of Management Board

Noubar AfeyanChairman of Board of Directors
Elizabeth NabelMember of Board of Directors
Francois NaderMember of Board of Directors
Robert LangerMember of Board of Directors
Sandra HorningMember of Board of Directors
Elizabeth TallettMember of Board of Directors
Paul SaganMember of Board of Directors
Stephen BerensonMember of Board of Directors
Stéphane BancelChairman of Managing Board
Corinne Le GoffMember of Executive Committee
David MelineMember of Executive Committee
Juan AndresMember of Executive Committee
Kate CroninMember of Executive Committee
Marcello DamianiMember of Executive Committee
Paul Burton, M.D.Member of Executive Committee
Shannon Thyme KlingerMember of Executive Committee
Stephen Hoge, M.D.Member of Executive Committee
Tracey FranklinMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.